Positive COVID Test? Sign up for a clinical trial.
A number of currently available drugs that may reduce the impact of COVID-19 are being evaluated. The Activ 6 Study is currently enrolling participants. Or check ClinicalTrials.gov for a complete list of clinical trials.
Project Topics
Fluvoxamine for COVID
Fluvoxamine is an existing medication that has shown great promise for treatment of COVID-19 infection. It is an SSRI (selective serotonin reuptake inhibitor) antidepressant that is commonly prescribed for obsessive-compulsive disorder.
Fluvoxamine’s ability to fight inflammation and block activation of platelets likely reduce the incidence of sepsis and blood clots that are common features of severe COVID-19 infection.
Results from a small randomized, placebo-controlled study of fluvoxamine was reported by researchers from Washington University. In 152 adult outpatients with symptomatic COVID-19, none treated with fluvoxamine had worsening symptoms but 8.3% of the control group got worse.
Additional real-world experience supported the use of fluvoxamine. In an outbreak of COVID-19 at the Golden Gates Field Racetrack, physicians offered fluvoxamine to the 113 individuals testing positive. In total, 65 persons opted for fluvoxamine, and 48 opted for observation alone. None of the patients selecting fluvoxamine were hospitalized and all recovered, while six of those not taking the medication (or 12.5%) were hospitalized, many had lingering symptoms, and one died.
The Together Trial is a randomized, controlled clinical trial conducted in Brazil that recently reported on the use of fluvoxamine for treatment of COVID-19. Of 1497 people with high-risk of serious COVID outcomes, 11% of those who received fluvoxamine required extended emergency room visits or hospitalization compared to 16% of those who received a placebo. For individuals who took most of the fluvoxamine doses, the death rate was reduced 91%.
Some physicians may offer existing medications like fluvoxamine off-label to COVID-19 patients. The ACTIV-6 trial is evaluating fluvoxamine for COVID treatment in the United States.
Take Action
If you recently tested positive for COVID, you can sign up for a clinical trial.
- ACTIV-6 – NIH trial evaluating fluvoxamine, fluticasone, ivermectin.
Additional Resources
Fluvoxamine
- Encyla review
- Hashimoto Y, Suzuki T, Hashimoto K. (2022). Mechanisms of action of fluvoxamine for COVID-19: a historical review. Mol Psychiatry. Jan 7 : 1–10. (free full text)
- Facente SN, Reiersen AM, Lenze EJ. (2021). Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence. Drugs. 81(18): 2081–2089. (free full text)
- Lenze EJ, Mattar C, Zorumski CF, et al. (2021). Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial. JAMA. 2020 Dec 8;324(22):2292-2300. (free full text)
- Reis G, Silva E, Silva D, et al. (2021). Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: The TOGETHER Randomized Platform Clinical Trial. Lancet Oct 27, 2021. (free full text)
- Seftel D, Boulware DR. (2021). Prospective cohort of fluvoxamine for early treatment of coronavirus disease 19. OFID 8(2):1-3. (free full text)
Human Health News
Overused medical tests more common at nonteaching and for-profit hospitals, particularly in the South
In its “Less is More” series of articles, the Journal of the American Medical Association documents the problems of overuse of medical care. “Overused” procedures
Arthritis drug helps fight COVID-19
A medication called baricitinib (brand name Olumiant), which is commonly used to treat rheumatoid arthritis, reduces the risk of death by 13% in hospitalized COVID-19
New idea for laboratory fish enrichment
You might not realize that a small fish is a common model in biomedical research. The zebrafish reproduces quickly and has external fertilization, rapid development,
Overused medical tests more common at nonteaching and for-profit hospitals, particularly in the South
In its “Less is More” series of articles, the Journal of the American Medical Association documents the problems of overuse of medical care. “Overused” procedures
Arthritis drug helps fight COVID-19
A medication called baricitinib (brand name Olumiant), which is commonly used to treat rheumatoid arthritis, reduces the risk of death by 13% in hospitalized COVID-19
New idea for laboratory fish enrichment
You might not realize that a small fish is a common model in biomedical research. The zebrafish reproduces quickly and has external fertilization, rapid development,
Supporting the future of male contraceptive research
The Male Contraceptive Initiative’s Youth Advisory Board recently selected four undergraduate students for awards to fund research in male contraception. The Parsemus Foundation is proud
